ATE161050T1 - Gen für die glykoprotease aus pasteurella haemolytica - Google Patents
Gen für die glykoprotease aus pasteurella haemolyticaInfo
- Publication number
- ATE161050T1 ATE161050T1 AT92902804T AT92902804T ATE161050T1 AT E161050 T1 ATE161050 T1 AT E161050T1 AT 92902804 T AT92902804 T AT 92902804T AT 92902804 T AT92902804 T AT 92902804T AT E161050 T1 ATE161050 T1 AT E161050T1
- Authority
- AT
- Austria
- Prior art keywords
- glycoprotease
- pct
- date aug
- pasteurella haemolytica
- gene
- Prior art date
Links
- 241001293418 Mannheimia haemolytica Species 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title 1
- 108020004414 DNA Proteins 0.000 abstract 2
- 102000053602 DNA Human genes 0.000 abstract 1
- 102000028180 Glycophorins Human genes 0.000 abstract 1
- 108091005250 Glycophorins Proteins 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919100825A GB9100825D0 (en) | 1991-01-15 | 1991-01-15 | Pasteurella haemolytica glycoprotease gene and the purified enzyme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE161050T1 true ATE161050T1 (de) | 1997-12-15 |
Family
ID=10688453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92902804T ATE161050T1 (de) | 1991-01-15 | 1992-01-15 | Gen für die glykoprotease aus pasteurella haemolytica |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5543312A (de) |
| EP (1) | EP0567503B1 (de) |
| AT (1) | ATE161050T1 (de) |
| CA (1) | CA2101781A1 (de) |
| DE (1) | DE69223502T2 (de) |
| DK (1) | DK0567503T3 (de) |
| GB (1) | GB9100825D0 (de) |
| WO (1) | WO1992013078A2 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5837268A (en) * | 1991-10-16 | 1998-11-17 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
| US5587305A (en) * | 1993-12-06 | 1996-12-24 | The United States Of America As Represented By The Department Of Agriculture | Pasteurella haemolytica transformants |
| US6793927B1 (en) * | 1993-12-06 | 2004-09-21 | The United States Of America As Represented By The Secretary Of The Department Of Agriculture | Construction of Pasteurella haemolytica vaccines |
| US5958730A (en) * | 1996-12-13 | 1999-09-28 | Eli Lilly And Company | Streptococcus pneumoniae gene sequence FtsY |
| GB9808423D0 (en) * | 1998-04-22 | 1998-06-17 | Glaxo Group Ltd | Bacterial polypeptide family |
| US6740113B2 (en) * | 1998-05-29 | 2004-05-25 | Scimed Life Systems, Inc. | Balloon expandable stent with a self-expanding portion |
| AU4392599A (en) * | 1998-06-25 | 2000-01-10 | Protegene Inc. | Human glycoprotease-like proteins and dnas encoding these proteins |
| US6220934B1 (en) * | 1998-07-23 | 2001-04-24 | Micron Technology, Inc. | Method for controlling pH during planarization and cleaning of microelectronic substrates |
| US6222026B1 (en) | 1998-09-08 | 2001-04-24 | Smithkline Beecham Corporation | Gcp |
| US6368815B1 (en) * | 1999-03-29 | 2002-04-09 | Warner-Lambert Company | Screening of molecules that inhibit human phosphodiesterase 4A produced by non-recombinant cell lines |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4503035B1 (en) * | 1978-11-24 | 1996-03-19 | Hoffmann La Roche | Protein purification process and product |
| US4906571A (en) * | 1986-10-06 | 1990-03-06 | University Of Guelph | Cell surface modification using a novel glycoproteinase of pasteurella haemolytica |
| US5082785A (en) * | 1987-01-30 | 1992-01-21 | Hoffmann-La Roche Inc. | Biosynthesis of 2 keto-l-gulonic acid |
-
1991
- 1991-01-15 GB GB919100825A patent/GB9100825D0/en active Pending
-
1992
- 1992-01-15 EP EP92902804A patent/EP0567503B1/de not_active Expired - Lifetime
- 1992-01-15 AT AT92902804T patent/ATE161050T1/de not_active IP Right Cessation
- 1992-01-15 DE DE69223502T patent/DE69223502T2/de not_active Expired - Fee Related
- 1992-01-15 US US08/087,797 patent/US5543312A/en not_active Expired - Fee Related
- 1992-01-15 CA CA002101781A patent/CA2101781A1/en not_active Abandoned
- 1992-01-15 DK DK92902804T patent/DK0567503T3/da active
- 1992-01-15 WO PCT/CA1992/000019 patent/WO1992013078A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2101781A1 (en) | 1992-07-16 |
| DE69223502D1 (de) | 1998-01-22 |
| EP0567503B1 (de) | 1997-12-10 |
| WO1992013078A2 (en) | 1992-08-06 |
| DK0567503T3 (da) | 1998-08-24 |
| GB9100825D0 (en) | 1991-02-27 |
| EP0567503A1 (de) | 1993-11-03 |
| WO1992013078A3 (en) | 1992-12-10 |
| DE69223502T2 (de) | 1998-07-16 |
| US5543312A (en) | 1996-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE161050T1 (de) | Gen für die glykoprotease aus pasteurella haemolytica | |
| GB9214873D0 (en) | Process for categorising nucleotide sequence populations | |
| ATE373094T1 (de) | Für kohlenhydratpolymere-bildende enzyme- kodierende dna-sequenzen und verfahren zur herstellung transgener pflanzen | |
| EP0088195A3 (de) | Messenger-RNS dessen Herstellung und Verwendung | |
| DE69131580D1 (de) | GDF-1 und UOG1 Proteine | |
| ES2153037T3 (es) | Lacasas purificadas de scytalidium y acidos nucleicos que las codifican. | |
| ATE149524T1 (de) | Dns, die ein menschliches, gefässverengendes peptid kodiert, und dessen verwendung | |
| ATE179754T1 (de) | Verfahren zur herstellung von thrombin | |
| NO951364L (no) | DNA-forbindelser omfattende sekvenser som koder for mannuronan C-5-epimersase | |
| HRP20010036B1 (hr) | Neurotrofni faktor rasta | |
| HUT46061A (en) | Dna sequences encoding hirudin-like protein and process for producing such proteins | |
| MX9708426A (es) | Polipeptido hk2 de variante estable. | |
| DE69630442D1 (de) | Ein neuartiger wachstumfaktor und eine genetische sequenz die für diesen kodiert | |
| DE3683447D1 (de) | Verfahren zur herstellung von humanlysozym. | |
| ES2059330T3 (es) | Un cdna codificador de antigeno carcinoembrionico. | |
| HUT77029A (hu) | A GAP-protein SH3 doménjéhez kötődni képes peptidek, ezeket kódoló nukleotidszekvenciák és előállításuk és alkalmazásuk | |
| SG66214A1 (en) | Novel chemotactic factor | |
| ZA9110087B (en) | Diagnosis for porcine malignant hyperthermia | |
| CO4480058A1 (es) | Genes codificantes y procedimiento de expresion de una nueva enzima: ftalil amidasa | |
| MX9206586A (es) | Proceso para la preparacion de daunorubicina. | |
| ATE215123T1 (de) | Or-1, ein wais-rezeptor der nuklearen rezeptoren familie | |
| PE20399A1 (es) | Muteina ob | |
| DE69637429D1 (de) | Gene, die für lymphocyte spezifischen interferon-regulationsfaktor (lsirf) polypeptide kodiert | |
| ATE423211T1 (de) | Produktion von proteinen, dafür kodierende plasmide und organismen, die solche plasmide enthalten | |
| EP1074972A3 (de) | Sprachsynthese mit multimodalen kodierten Einheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |